Legionella Testing Market

Market Study on Legionella Testing: PMR Anticipates a Spectrum of Growth Prospects for Laboratories in the Coming Years, Analysing the Heightened Awareness of Waterborne Infections, Increasing Regulatory Focus on Water Safety, and the Growing Importance of Legionella Prevention in Healthcare and Industrial Settings

A Detailed Analysis of the Legionella Testing Market Based on Stringent Regulatory Requirements for Water Quality Testing, Growing Concerns over Waterborne Diseases, and Increasing Awareness of Legionnaires' Disease Prevention

Industry: Healthcare

Published Date: January-2024

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 217

Report ID: PMRREP33962

Report Price

$ 4900*

Buy Now

Market Outlook ( 2024-2031)

The global legionella testing market is forecast to expand at a CAGR of 8.5% and thereby increase from a value of US$298.2 Mn in 2024, to US$527.9 Mn by the end of 2031.

Attributes

Key Insights

Legionella Testing Market Size (2024E)

US$298.2 Mn

Projected Market Value (2031F)

US$527.9 Mn

Global Market Growth Rate (2024 to 2031)

8.5%

Historical Market Growth Rate (2019 to 2023)

6.8%

Market Introduction and Definition

Legionella testing pertains to the evaluation and identification of Legionella bacteria, with a specific focus on Legionella pneumophila, the causative agent of Legionnaires' disease—a critically ill variant of pneumonia. Inhaling aerosolized water droplets poses a risk since Legionella thrives in water systems such as cooling towers, hot tubs, and plumbing systems. This poses a risk to individuals who are susceptible to the disease. To verify the security of water sources and stop outbreaks, testing entails examining water samples for the presence of Legionella.

The market for Legionella testing is experiencing tremendous expansion due to greater awareness of Legionnaires' illness and strong laws that promote water safety. There are numerous testing methods and technologies available on the market, which creates potential for diagnostic laboratories and manufacturers of Legionella testing kits and equipment. The market's primary focus is on preventing outbreaks and ensuring public health.

Market Growth Drivers

Stringent Regulatory Frameworks, and Growing Concerns Around Public Health

The market for Legionella testing is being driven by the enforcement of strict regulations designed to protect public health. Legionella outbreaks can be avoided by closely monitoring and managing the bacteria in water systems, as governments and health organizations throughout the world are realizing more and more. Strict laws require frequent testing and adherence to certain safety requirements in a number of sectors, including manufacturing, hospitality, and healthcare. Due to the necessity of investing in Legionella testing to guarantee the security of their water systems, businesses, and institutions are creating a demand for testing services, kits, and technology.

Another important factor propelling the market for Legionella testing is the growing public awareness of the disease and its possible effects on public health. People, companies, and government are becoming more concerned as the number of Legionella outbreaks rises and as it becomes clearer how the bacterium can live in a variety of water sources. Comprehensive testing programs for Legionella are being implemented proactively as a result of this heightened awareness. In order to address these issues and maintain public health standards, businesses and institutions are proactively assessing and mitigating the hazards associated with Legionella contamination. This has created a demand for sophisticated testing methods and technology.

Market Restraints

High Expenses, and Intricate Testing Procedures

A significant impediment to the Legionella testing market is the intricacy of testing protocols and the corresponding elevated expenses. Extensive laboratory procedures, skilled staff, and specialized equipment are frequently needed to provide comprehensive and accurate Legionella testing. Due to the complexity of these processes, smaller companies or facilities with fewer resources may find it difficult to implement thorough Legionella testing programs, which could impede the expansion of the industry as a whole.

Complicated Regulatory Environment

Navigating the complicated regulatory environment governing water safety standards is one of the biggest challenges facing the Legionella testing industry. Businesses and testing service providers have difficulties due to the diverse and frequently changing rules that exist across many industries and areas. It can take a lot of resources to continuously monitor and change in order to meet these many criteria. To ensure compliance and successfully traverse the complex regulatory framework, businesses in the Legionella testing sector need to invest in keeping up to date with regulatory developments.

Opportunities

Advancements in Testing Technologies

Constant advancements in testing technologies contribute to the Legionella testing market's promising potential. Legionella testing procedures are becoming more accurate and efficient thanks to advances in molecular biology, genomics, and fast detection techniques. These developments aid in the creation of testing solutions that are affordable in addition to improving detection speed and sensitivity. The market will open up new potential for manufacturers who spend in R&D to bring innovative technologies to market. This will give them a competitive edge in fulfilling the growing need for more advanced and user-friendly Legionella testing kits.

Moreover, there is a big market expansion potential when automation and the Internet of Things (IoT) are combined with Legionella testing. Water systems may be continuously monitored thanks to real-time data on water quality provided by automated monitoring systems and smart sensor technology. This facilitates testing procedures and enables quick reactions to any possible Legionella contamination. Companies that use automation and the Internet of Things to create user-friendly remote monitoring solutions can take advantage of a quickly developing market niche as organizations and businesses look for more effective and cutting-edge ways to guarantee water safety and regulatory compliance.

Market Segmentation

Which is the Dominant Test Type Segment?

Culture Media to be the Dominant Segment by Test Type

The test type segment is divided into culture media, urine antigen testing, direct fluorescent antibody, and PCR. Culture Media dominates the Legionella testing market due to its well-established reputation and consistent ability to identify Legionella bacteria. Culture media methods are widely used in laboratories to cultivate and isolate Legionella colonies, yielding accurate findings. The method's dominance in the market is partly attributed to its longstanding reputation, especially in the fields of environmental testing and healthcare.

PCR is the most rapidly expanding segment, driven by its exceptional sensitivity and specificity in the detection of Legionella DNA. The method's increasing popularity in Legionella testing can be attributed to its quick turnaround time, precision in detecting low concentrations, and automation adaptability. This is especially true in environments where timely and accurate findings are required.

Which Area of Application will be Prominent?

Water Testing Applications to Surge Ahead amid Regulatory Oversight, and Public Safety Emphasis

The Applications segment is sub-segmented into water testing and IVD testing. Water testing is the most used method for testing for Legionella, mostly due to regulatory oversight and the need to guarantee water safety in a variety of businesses. Legionella testing services are in high demand due to strict laws requiring regular testing in various water systems, including cooling towers and plumbing networks.

Water testing is important for preserving public health and safety because of the focus on preventing waterborne illnesses and outbreaks. The fastest-growing segment is IVD testing, driven by improvements in diagnostic technologies and an increasing emphasis on early Legionella infection identification. The application's quick rise is partly due to its capability to provide quick and accurate findings, especially in clinical contexts. IVD testing for Legionella is being adopted at a quick rate in the industry due to the growing awareness of the disease and the urgency of timely diagnosis.

Which End User is Dominant?

Emphasis on Patient Safety Drives Dominance of Hospitals and Clinics

The End User segment is categorized into hospitals and clinics, diagnostic labs, and water treatment industries. Hospitals and clinics account for the greatest part of Legionella testing, driven by the important requirement for early detection and prevention of Legionnaires' disease in healthcare settings. The need for testing services and equipment in hospitals and clinics is increased by the high-risk environment of healthcare institutions, which demands stringent Legionella testing to protect patients and workers. The water treatment industry is the most rapidly expanding sector, driven by heightened consciousness regarding the potential hazards of Legionella contamination in water systems. Legionella testing services are in high demand due to strict laws and proactive measures taken by water treatment companies to ensure a safe supply of water. These factors have also contributed to the segment's quick expansion.

Top Regional Markets

North America's Dominance Upheld by Strong Regulatory Compliance

The dominance of North America in the Legionella testing market can be attributed to several factors, including rigorous regulatory frameworks, increased public consciousness regarding Legionnaires' disease, and a resilient healthcare infrastructure. Legionella testing services are in high demand because of strict rules governing water safety in enterprises and healthcare facilities. Because of the region's strong public health policies and well-established diagnostic sector, North America leads the world in the market for Legionella testing.

East Asia's Anticipates Explosive Growth Prospects

Legionella testing in East Asia is experiencing the most rapid growth due to factors such as rapid industrialization, expanding urban areas, and an increased focus on public health. There is a greater awareness of the problems associated with Legionella contamination in water systems as industry and metropolitan areas grow. Demand for Legionella testing services has surged in East Asia due to government measures to enhance water quality and an increase in healthcare facilities. Proactive health measures and a dynamic economic landscape drive the region's quick rise in the Legionella testing market.

Analyst’s Viewpoint

The market for Legionella testing is characterized by dynamic changes and steady expansion. The need for Legionella testing is expected to expand steadily due to the global emphasis on water safety and strict regulatory frameworks. Testing technology advancements like polymerase chain reaction (PCR) and quick detection techniques have the potential to completely change the diagnostic market by providing more precise and effective tests. It is anticipated that automation and Internet of Things (IoT) integration will become more popular, offering real-time monitoring and faster testing procedures.

Opportunities for market expansion in areas like East Asia are anticipated to increase as awareness of the disease about Legionnaires' disease continues to rise, especially in emerging nations. The market is expected to flourish in the near future despite obstacles presented by the complicated regulatory environment. Proactive steps to maintain water safety are becoming more and more important to businesses and institutions, which will fuel demand for cutting-edge Legionella testing solutions.

Supply-side Dynamics

The Legionella testing market is characterized by supply-side dynamics that include an increasing influx of technologically improved testing solutions and increased cooperation between research institutes and manufacturers. The ability to provide a wide range of Legionella testing services is something that laboratories and diagnostic service providers are continually working to expand. To increase the sensitivity and specificity of Legionella detection, manufacturers are spending R&D to create cutting-edge testing technologies such as PCR-based techniques and sophisticated culture media formulations. In addition to satisfying the strict regulatory criteria, the ongoing development of testing apparatus and procedures is also addressing the growing need for quick, precise, and affordable Legionella testing.

A strong supply chain is also being promoted via strategic alliances and collaborations between manufacturers and medical facilities, the water treatment sector, and diagnostic labs. Because of this cooperative approach, customized solutions may be developed to satisfy the unique requirements of various end-user sectors. In addition, with rising knowledge of the risks associated with Legionella, manufacturers are concentrating on broadening their geographic reach to access emerging markets. To fulfil the rising demand, attempts to improve manufacturing capabilities and guarantee a steady and dependable supply of testing kits, reagents, and equipment also have an impact on the supply-side dynamics.

Competitive Intelligence and Business Strategy

The market for Legionella testing is highly competitive, with major competitors spending in R&D to launch innovative technologies, broaden their product offerings, and obtain a competitive advantage. To improve their market position, top businesses regularly participate in strategic activities, including collaborations, mergers, and acquisitions. It is usual for businesses to collaborate with diagnostic labs, water treatment businesses, and healthcare facilities in order to provide complete Legionella testing solutions that are customized to meet the specific needs of various end-user sectors.

Market participants are also concentrating on geographic expansion in an effort to enter unexplored markets and profit from rising public awareness of the risks associated with Legionella. Efforts to maintain regulatory compliance also impact competitive dynamics since market participants need to adhere to strict standards in order to gain the trust and credibility of end consumers. With a focus on technological innovation, strategic alliances, and a customer-centric approach to address the changing needs of industries and healthcare sectors in ensuring water safety and preventing Legionnaires' disease outbreaks, it is anticipated that as the market continues to evolve, the competitive landscape will witness intensified competition.

Key Recent Developments

New Product Launch

The Polish counterintelligence organization ABW is looking into whether the city of Rzeszów was intentionally contaminated after Legionella bacteria were found in the city's water supply system in August 2024.

Market Impact: As authorities and businesses prioritize water safety measures to tackle potential contamination threats, the confirmation of Legionella bacteria in the water supply network of Rzeszów, Poland, with a continuing counterintelligence investigation, may increase demand for Legionella testing products and technologies in the region.

The inventive Canadian business Tecta-PDS, which automated water microbiology testing for criteria including E. coli and total coliforms, was purchased by IDEXX, the world leader in rapid microbiology testing for water, in November 2022. Through the acquisition, IDEXX will be able to provide more choices for laboratory-based and field-based water microbial testing.

Market Impact: The market for water microbiology testing is improved by IDEXX's acquisition of Tecta-PDS since it incorporates automation into testing procedures and provides effective solutions for total coliform and E. coli. This action expands IDEXX's testing capabilities to include in-field and laboratory testing, which could have an impact on innovation and market competitiveness.

In May 2022, ChemREADY declared the beginning of its new product program and services for Legionella aimed at fighting the water-borne virus in building water systems.

Market Impact: The launch of ChemREADY's new product program and services for Legionella represents a market response to the expanding need for Legionella control. This project is probably going to help the industry expand by giving companies and sectors more resources and services to deal with water-borne pathogen issues efficiently.

Legionella Testing Market Report Scope

Attribute

Details

Forecast Period

2024 to 2031

Historical Data Available for

2019 to 2023

Market Analysis

US$ Million for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa  

Key Countries Covered

  • United States
  • Canada
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand
  • GCC Countries
  • South Africa  

Key Market Segments Covered

  • Test Type
  • Application
  • End User
  • Region

Key Companies Profiled

  • Abbott
  • Beckman Coulter, Inc.
  • BD
  • Bio-Rad Laboratories, Inc.
  • BIOMÉRIEUX
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc.
  • Pro Lab Diagnostics Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Report Coverage

  • Market Forecast
  • Company Share Analysis
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives  

Customization & Pricing

Available upon request

Legionella Testing Market Research Segmentation

By Test Type:

  • Culture Media
  • Urine Antigen Testing
  • Direct Fluorescent Antibody
  • PCR

By Application:

  • Water Testing
  • IVD Testing

By End User:

  • Hospitals and Clinics
  • Diagnostic Labs
  • Water Treatment Industries

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • Abbott
  • Beckman Coulter, Inc.
  • BD
  • Bio-Rad Laboratories, Inc.
  • BIOMÉRIEUX
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc.
  • Pro Lab Diagnostics Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Frequently Asked Questions

The market is anticipated to grow at a CAGR of 8.5% during the projected period.

The Legionella testing market was valued at US$298.2 million in 2023.

The US held the largest market share in 2023.

Some of the prominent players in the market are Abbott, Beckman Coulter, Inc., BD, Bio-Rad Laboratories, Inc., BIOMÉRIEUX, Eiken Chemical Co., Ltd., Hologic, Inc., Pro Lab Diagnostics Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Takara Bio Inc., and Thermo Fisher Scientific Inc.

The IVD testing (In-Vitro Diagnostic Testing) segment is expected to grow at the fastest CAGR during the forecast period.

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate